Pharmacist's Letter | CE & Recommendations You Can Trust

September 2023 Issue

Know What’s New for 2023-2024 Flu Immunizations

You’ll play a key role in optimizing flu vaccines for 2023-2024...

Resources

FAQ: Flu Vaccines for 2023-24

Help Patients Age 60 and Over Decide About the RSV Vaccine

We’re getting questions about the first vaccines to prevent respiratory syncytial virus (RSV) in older adults...

Be Ready to Manage Treatment-Resistant Depression

One in 3 adults with depression don’t experience significant improvement...

Know How Bexagliflozin Stacks Up to Other SGLT2 Inhibitors

New bexagliflozin (Brenzavvy) will try to shake up the SGLT2 inhibitor market...

GO TO FULL ISSUE

CE & Training

Podcast: Cardiovascular Risks with Testosterone

CE-in-the-Letter: Pharmacist's Letter September 2023

Live CE: Pharmacy Essential Updates September 2023

Self Study CE: Conflict Prevention and Management

GO TO CE & TRAINING ORGANIZER >

Free Clinical Resources

Beers List of Potentially Harmful Drugs

COVID-19 Treatments of Interest

Comparison of Insulins

GO TO ALL CLINICAL RESOURCES >

What is Pharmacist’s Letter?

Pharmacist's Letter is the resource trusted by over 200,000 pharmacists for staying current on medication recommendations and taking and tracking CE. Learn more >

Developing Your Pharmacy Career

Pharmacist's Letter is one of many CE and training solutions from TRC Healthcare. We support pharmacists like you at all stages of their career. Learn more about:

Solutions for Hospital Pharmacists

Advanced Resources for Natural Medicines

Training on Cannabis for Pharmacists